Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Diacylglycerol (18:0/22:6) (Model 1)

XKR6 · rs28486007

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−13, with 4 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 7,069 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.15 lower; p = 7 × 10−14.

Where it sits Chromosome 8, band 8p23.1 — in an intron of XKR6.

How common each version is

AG
Korean KRGDB
A 7.9% · G 92.1%
Korean Korea4K
A 8.9% · G 91.1%
Korean Korea1K
A 7.5% · G 92.5%
Japanese ToMMo
A 10.9% · G 89.1%
Vietnamese
A 8.5% · G 91.5%
World gnomAD
A 22.5% · G 77.5%
World 1000 Genomes
A 20.4% · G 79.6%
World TOPMed
A 22.1% · G 78.0%

By ancestry gnomAD

East Asian
A 10.4% · G 89.6%
European (non-Finnish)
A 26.3% · G 73.7%
African / African American
A 18.2% · G 81.8%
South Asian
A 21.8% · G 78.2%
Admixed American (Latino)
A 19.4% · G 80.5%
Middle Eastern
A 21.4% · G 78.6%
Finnish
A 22.9% · G 77.1%
Ashkenazi Jewish
A 30.7% · G 69.3%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Diacylglycerol (18:0/22:6) (Model 1). That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Diacylglycerol (18:0/22:6) (Model 1). That is a smaller link than two copies.
G/G No copy of the version the research linked to Diacylglycerol (18:0/22:6) (Model 1). This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Diacylglycerol (18:0/22:6) (Model 1) (rs28486007). MyGeneLog™. https://www.mygenelog.com/variants/rs28486007

← See all variants